Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients

American Journal of Psychiatry

Volumn 163, Issue 1, 2006, Pages 73-78

  Taylor, Bonnie P ^a   Bruder, Gerard E ^a   Stewart, Jonathan W ^a   McGrath, Patrick J ^a   Halperin, Jeffrey ^a   Ehrlichman, Howard ^a   Quitkin, Frederic M ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; CONTROLLED ORAL WORD ASSOCIATION TEST FAS; CONTROLLED STUDY; DEPRESSION; DEPTH PERCEPTION; DOPAMINERGIC TRANSMISSION; DRUG RESPONSE; FEMALE; HUMAN; INTELLIGENCE; INTELLIGENCE TEST; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; OUTPATIENT CARE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR DISORDER; PSYCHOPHARMACOTHERAPY; STROOP COLOR AND WORD TEST; TASK PERFORMANCE; VERBAL BEHAVIOR;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; DEPRESSIVE DISORDER, MAJOR; DOPAMINE; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROBABILITY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME;

EID: 30044448181     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.163.1.73     Document Type: Article

References (33)

1. Rush AJ, Trivedi M, Fava M: Depression, IV: STAR*D treatment trial for depression (image, neuro). Am J Psychiatry 2003; 160:237
2. van Praag HM, Korf J: Retarded depression and the dopamine metabolism. Psychopharmacologia 1971; 19:199-203
3. Post RM, Kotin J, Goodwin FK, Gordon EK: Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry 1973; 130:67-72
4. Ebert D, Feistel H, Loew T, Pirner A: Dopamine and depression-striatal dopamine D2 receptor SPECT before and after antidepressant therapy. Psychopharmacology (Berl) 1996; 126:91-94
5. Paillère Martinot M-L, Bragulat V, Artiges E, Dollé F, Hinnen F, Jouvent R, Martinot J-L: Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. Am J Psychiatry 2001; 158:314-316
6. Shah PJ, Ogilvie AD, Goodwin GM, Ebmeier KP: Clinical and psychometric correlates of dopamine D2 binding in depression. Psychol Med 1997; 27:1247-1256
7. Gotham AM, Brown RG, Marsden CD: "Frontal" cognitive function in patients with Parkinson's disease "on" and "off" levodopa. Brain 1988; 111(part 2):299-321
8. Dolan RJ, Bench CJ, Liddle PF, Friston KJ, Frith CD, Grasby PM, Frackowiak RS: Dorsolateral prefrontal cortex dysfunction in the major psychoses: symptom or disease specificity? J Neurol Neurosurg Psychiatry 1993; 56:1290-1294
9. Galynker II, Cai J, Ongseng F, Finestone H, Dutta E, Serseni D: Hypofrontality and negative symptoms in major depressive disorder. J Nucl Med 1998; 39:608-612
10. Mayberg HS, Lewis PJ, Regenold W, Wagner HN Jr: Paralimbic hypoperfusion in unipolar depression. J Nucl Med 1994; 35:929-934
11. Videbech P, Ravnkilde B, Pedersen TH, Hartvig H, Egander A, Clemmensen K, Rasmussen NA, Andersen F, Gjedde A, Rosenberg R: The Danish PET/Depression Project: clinical symptoms and cerebral blood flow: a regions-of-interest analysis. Acta Psychiatr Scand 2002; 106:35-44
12. Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM: Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46:243-250
13. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME: A functional anatomical study of unipolar depression. J Neurosci 1992; 12:3628-3641
14. Berman KF, Illowsky BP, Weinberger DR: Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, IV: further evidence for regional and behavioral specificity. Arch Gen Psychiatry 1988; 45:616-622
15. Weinberger DR, Berman KF, Zee RF: Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow evidence. Arch Gen Psychiatry 1986; 43:114-124
16. Dunkin JJ, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S: Executive dysfunction predicts nonresponse to fluoxetine in major depression. J Affect Disord 2000; 60:13-23
17. Benton AL, Hamsher K, Sivan AB: Multilingual Aphasia Examination (3rd ed.). Iowa City, AJA Associates, 1983
18. Golden CJ: Stroop Color and Word Test: A Manual for Clinical and Experimental Uses. Wood Dale, III, Stoelting Co, 1978
19. Tombaugh TN, Kozak J, Rees L: Normative data for the Controlled Oral Association Test (1996), in A Compendium of Neuropsychological Tests, 2nd ed. Edited by Spreen O, Strauss E. New York, Oxford University Press, 1998, pp 453-457
20. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G: Wisconsin Card Sorting Test Manual. Odessa, Fla, Psychological Assessment Resources, 1993
21. Rampello L, Nicoletti G, Raffaele R: Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses. Acta Psychiatr Scand 1991; 84:552-554
22. Kalayam B, Alexopoulos GS: Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry 1999; 56:713-718
23. Bruder GE, Stewart JW, McGrath PJ, Deliyannides D, Quitkin FM: Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men. Neuropsychopharmacology 2004; 29:1742-1761
24. Bruder GE, Otto MW, McGrath PJ, Stewart JW, Fava M, Rosenbaum JF, Quitkin FM: Dichotic listening before and after fluoxetine treatment for major depression: relations of laterality to therapeutic response. Neuropsychopharmacology 1996; 15:171-179
25. Bruder GE, Stewart JW, Tenke CE, McGrath PJ, Leite P, Bhattacharya N, Quitkin FM: Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant. Biol Psychiatry 2001; 49:416-425
26. Ravnkilde B, Videbech P, Rosenberg R, Gjedde A, Gade A: Putative tests of frontal lobe function: a PET-study of brain activation during Stroop's test and verbal fluency. J Clin Exp Neuropsychol 2002; 24:534-547
27. Frith CD, Friston KJ, Liddle PF, Frackowiak RS: A PET study of word finding. Neuropsychologia 1991; 29:1137-1148
28. Friston KJ, Frith CD, Liddle PF, Frackowiak RS: Investigating a network model of word generation with positron emission tomography. Proc R Soc Lond B Biol Sci 1991; 244:101-106
29. Schlosser R, Hutchinson M, Joseffer S, Rusinek H, Saarimaki A, Stevenson J, Dewey SL, Brodie JD: Functional magnetic resonance imaging of human brain activity in a verbal fluency task. J Neurol Neurosurg Psychiatry 1998; 64:492-498
30. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT: Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997; 8:1057-1061
31. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, Oakes TR, Larson CL, Abercrombie HC, Schaefer SM, Koger JV, Benca RM, Davidson RJ: Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001; 158:405-415
32. Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR Jr: Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry 2003; 160:522-532
33. Davidson RJ, Irwin W, Anderle MJ, Kalin NH: The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003; 160:64-75